Electromed: Blowout Quarter, Beneficial 2024 Guidance, And Cheap [Seeking Alpha]
Electromed, Inc. (ELMD)
NASDAQ:AMEX Investor Relations:
smartvest.com/electromed/investor-relations
Company Research
Source: Seeking Alpha
The company's growth strategies, including direct-to-consumer marketing and internationalization efforts, could drive significant net sales growth. Electromed's stock repurchase program and recent price dynamics make it an attractive investment opportunity. Electromed, Inc. ( NYSE: ELMD ) recently reported an impressive quarter, and noted beneficial expectations for the year 2024. With a total market opportunity of close to 4.2 million patients suffering from Bronchiectasis, I assumed that the total market opportunity could be around $8.4 billion. Given the current revenue line, there is significant room for improvement thanks to direct-to-consumer and medical marketing as well as internationalization efforts. If we also include the stock repurchase program and the recent price dynamics, I believe that Electromed is a buy. Yes, there are relevant risks out there coming from higher costs, longer delivery times, or supply chain issues. With that, I believe that ELMD does not trade
Show less
Read more
Impact Snapshot
Event Time:
ELMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELMD alerts
High impacting Electromed, Inc. news events
Weekly update
A roundup of the hottest topics
ELMD
News
- Electromed, Inc. (NYSE: ELMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Electromed, Inc. Schedules its Third Quarter Fiscal 2024 Financial Results Conference Call for May 7, 2024 at 5:00 p.m. ETBusiness Wire
- Electromed, Inc. (NYSE: ELMD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Electromed, Inc. (NYSE: ELMD) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.MarketBeat
- Electromed, Inc. to Participate in the 2024 Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]Yahoo! Finance
ELMD
Analyst Actions
- 2/22/24 - TheStreet
ELMD
Sec Filings
- 3/5/24 - Form 4
- 2/14/24 - Form SC
- 2/13/24 - Form SC
- ELMD's page on the SEC website